Article info

Original research
Randomized phase II trial of avelumab alone or in combination with cetuximab for patients with previously treated, locally advanced, or metastatic squamous cell anal carcinoma: the CARACAS study

Authors

  1. Correspondence to Dr Sara Lonardi; sara.lonardi{at}iov.veneto.it
View Full Text

Citation

Lonardi S, Prete AA, Morano F, et al
Randomized phase II trial of avelumab alone or in combination with cetuximab for patients with previously treated, locally advanced, or metastatic squamous cell anal carcinoma: the CARACAS study

Publication history

  • Accepted September 7, 2021
  • First published November 23, 2021.
Online issue publication 
November 23, 2021
  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.